Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 32% ± 19% | |
lung | 17 studies | 26% ± 8% | |
peripheral blood | 16 studies | 30% ± 9% | |
intestine | 9 studies | 22% ± 7% | |
eye | 9 studies | 28% ± 10% | |
kidney | 6 studies | 23% ± 3% | |
liver | 5 studies | 32% ± 12% | |
bone marrow | 4 studies | 21% ± 4% | |
breast | 4 studies | 18% ± 2% | |
adipose | 4 studies | 25% ± 3% | |
uterus | 3 studies | 36% ± 16% | |
lymph node | 3 studies | 31% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2279.25 | 1445 / 1445 | 100% | 21.62 | 183 / 183 |
prostate | 100% | 3660.89 | 245 / 245 | 100% | 25.41 | 501 / 502 |
lung | 100% | 3157.31 | 578 / 578 | 99% | 13.07 | 1141 / 1155 |
brain | 100% | 2499.96 | 2635 / 2642 | 99% | 10.07 | 696 / 705 |
stomach | 100% | 2504.17 | 359 / 359 | 98% | 17.77 | 279 / 286 |
breast | 100% | 3269.96 | 459 / 459 | 97% | 15.47 | 1089 / 1118 |
thymus | 100% | 3372.71 | 653 / 653 | 97% | 13.93 | 589 / 605 |
ovary | 100% | 3484.76 | 180 / 180 | 97% | 8.11 | 416 / 430 |
intestine | 100% | 3423.22 | 966 / 966 | 97% | 15.84 | 509 / 527 |
pancreas | 99% | 1837.31 | 326 / 328 | 97% | 16.26 | 173 / 178 |
kidney | 100% | 2664.36 | 89 / 89 | 95% | 14.40 | 853 / 901 |
bladder | 100% | 3023.52 | 21 / 21 | 94% | 9.50 | 472 / 504 |
uterus | 100% | 2776.70 | 170 / 170 | 92% | 7.91 | 420 / 459 |
adrenal gland | 100% | 2871.05 | 258 / 258 | 90% | 9.66 | 206 / 230 |
skin | 100% | 2484.65 | 1808 / 1809 | 82% | 9.06 | 385 / 472 |
liver | 100% | 1285.93 | 226 / 226 | 64% | 4.93 | 259 / 406 |
adipose | 100% | 2690.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2658.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2932.14 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1578.20 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1361.77 | 830 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 5.78 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 8.49 | 23 / 29 |
peripheral blood | 77% | 1597.29 | 719 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 4.77 | 46 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0071955 | Biological process | recycling endosome to Golgi transport |
GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
GO_0034453 | Biological process | microtubule anchoring |
GO_0031023 | Biological process | microtubule organizing center organization |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0034499 | Biological process | late endosome to Golgi transport |
GO_0090161 | Biological process | Golgi ribbon formation |
GO_0034067 | Biological process | protein localization to Golgi apparatus |
GO_0070861 | Biological process | regulation of protein exit from endoplasmic reticulum |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | GCC2 |
Protein name | GRIP and coiled-coil domain containing 2 GCC2 protein GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53) |
Synonyms | KIAA0336 RANBP2L4 |
Description | FUNCTION: Golgin which probably tethers transport vesicles to the trans-Golgi network (TGN) and regulates vesicular transport between the endosomes and the Golgi. As a RAB9A effector it is involved in recycling of the mannose 6-phosphate receptor from the late endosomes to the TGN. May also play a role in transport between the recycling endosomes and the Golgi. Required for maintenance of the Golgi structure, it is involved in the biogenesis of noncentrosomal, Golgi-associated microtubules through recruitment of CLASP1 and CLASP2. . |
Accessions | ENST00000409896.1 U3KQE0 ENST00000492785.1 ENST00000687399.1 A0A8I5KW38 ENST00000482325.5 [Q8IWJ2-3] A0A8I5QJB7 B8ZZW2 ENST00000692694.1 A0A8I5KVA2 ENST00000685519.1 A0PJA5 H7BYJ9 B8ZZA5 ENST00000309863.11 [Q8IWJ2-1] U3KPU4 Q8IWJ2 ENST00000393321.2 ENST00000462897.2 ENST00000409821.5 |